Exercise Capacity in Diseases and Health

Exercise Capacity Clinical Trial

Official title:

Exercise Capacity in Diseases and Health

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT02575469
• Other study ID #: 0323-14- RMB-CTIL
• Status: Not yet recruiting
• Phase: N/A
• First received: October 12, 2015
• Last updated: January 23, 2017
• Start date: October 1, 2017
• Est. completion date: January 1, 2036

Study information

• Verified date: January 2017
• Source: Rambam Health Care Campus
• Contact: Abraham Lorber, MD
• Phone: +972-4-7774630
• Email: a_lorber[@]rambam.health.gov.il
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Exercise capacity is a key factor to evaluate and treat patients in different diseases (e.g. ischemic heart disease, chronic obstructive pulmonary disease, cystic fibrosis). The best way to measure exercise capacity is to perform a cardiopulmonary exercise testing. Normal/reference values in health and disease relate to specific population and subpopulations. The population in Israel is unique in its diversity.

Objectives: Data collection of exercise capacity assessment in health and illness in the northern of Israel for future local database.

Population: 500 Patients evaluated routinely in the exercise lab (pediatric cardiology institute) and healthy volunteers evaluated as controls.

Study design: Prospective observational study. Participants will answer a health related questioner, undergo a physical examination, perform a cardiopulmonary exercise test on a treadmill or a cycle ergometer.

Description:

Exercise capacity is a key factor to evaluate and treat patients in different diseases (e.g. ischemic heart disease, chronic obstructive pulmonary disease, cystic fibrosis). The best way to measure exercise capacity is to perform a cardiopulmonary exercise testing. Normal/reference values in health and disease relate to specific population and subpopulations. The population in Israel is unique in its diversity.

Objectives: Data collection of exercise capacity assessment in health and illness in the northern of Israel for future local database.

Population: 500 Patients evaluated routinely in the exercise lab (pediatric cardiology institute) and healthy volunteers evaluated as controls.

Study design: Prospective observational study. Participants will answer a health related questioner, undergo a physical examination, perform a cardiopulmonary exercise test on a treadmill or a cycle ergometer .

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 500
• Est. completion date: January 1, 2036
• Est. primary completion date: October 1, 2035
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 6 Years to 90 Years

Eligibility

Inclusion Criteria:

• Ability to complete full exercise evaluation (including cardiopulmonary exercise testing).

Exclusion Criteria:

• Acute illness on visit day.

• for healthy volunteers: chronic disease or use of medications.

• Professional athletes.

Related Conditions & MeSH terms

• Exercise Capacity

Locations

Country	Name	City	State
Israel	RAMBAM health care center	Haifa

Sponsors (1)

Lead Sponsor	Collaborator
Rambam Health Care Campus

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	VO2 (oxygen consumption)		30 minutes